• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov14
Aytu BioPharma released FY2026 Q1 earnings on November 13 After-Market (EST), actual revenue USD 13.89 M (forecast USD 12.6 M), actual EPS USD -0.0772 (forecast USD -0.255)
00:00
Nov6
Aytu BioPharma to release FY2026 Q1 earnings on November 13 After-Market EST, forecast revenue USD 12.6 M, EPS USD -0.255
00:08
Sep23
Aytu BioPharma released FY2025 earnings on September 23 After-Market EST, actual revenue USD 66.38 M (forecast USD 69.15 M), actual EPS USD -2.1596 (forecast USD 0.66)
23:00
Aytu BioPharma released FY2025 Q4 earnings on September 23 After-Market EST, actual revenue USD 15.14 M (forecast USD 17.92 M), actual EPS USD -2.918 (forecast USD -0.05)
23:00
Sep16
Aytu BioPharma to Release FY2025 Q4 Earnings on September 23 After-Market EST, Forecast Revenue USD 17.92 M, EPS USD -0.05
00:05
Jun23
Aytu BioPharma Expands Loan Agreement and Secures Public Offering
12:01

Schedules & Filings

Schedules
Filings
Nov13
Earning Release(EST)

FY2026 Q1 Earning Release (USD) Revenue 13.89 M, Net Income 1.965 M, EPS -0.0772

Sep23
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Revenue 15.14 M, Net Income -19.82 M, EPS -2.918

May14
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 18.45 M, Net Income 3.994 M, EPS 0.2065

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
AMCI
7.270
+168.27%
+4.560
RADX
10.630
+149.53%
+6.370
ARTV
6.300
+90.91%
+3.000
NTCL
0.9500
+39.71%
+0.270
MASK
0.4100
+36.35%
+0.109
QIPT
3.500
+34.10%
+0.890
KXIN
4.440
+33.73%
+1.120
ASTI
4.170
+33.65%
+1.050
CLIK
7.200
+28.34%
+1.590
CLYM
3.810
+27.00%
+0.810
View More